1. Home
  2. NKTR vs RCAT Comparison

NKTR vs RCAT Comparison

Compare NKTR & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • RCAT
  • Stock Information
  • Founded
  • NKTR 1990
  • RCAT 2002
  • Country
  • NKTR United States
  • RCAT United States
  • Employees
  • NKTR N/A
  • RCAT N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • RCAT Wholesale Distributors
  • Sector
  • NKTR Health Care
  • RCAT Industrials
  • Exchange
  • NKTR Nasdaq
  • RCAT Nasdaq
  • Market Cap
  • NKTR 247.9M
  • RCAT 248.8M
  • IPO Year
  • NKTR 1994
  • RCAT 2017
  • Fundamental
  • Price
  • NKTR $0.93
  • RCAT $10.72
  • Analyst Decision
  • NKTR Buy
  • RCAT Strong Buy
  • Analyst Count
  • NKTR 3
  • RCAT 1
  • Target Price
  • NKTR $4.00
  • RCAT $4.00
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • RCAT 12.1M
  • Earning Date
  • NKTR 11-07-2024
  • RCAT 12-16-2024
  • Dividend Yield
  • NKTR N/A
  • RCAT N/A
  • EPS Growth
  • NKTR N/A
  • RCAT N/A
  • EPS
  • NKTR N/A
  • RCAT N/A
  • Revenue
  • NKTR $93,137,000.00
  • RCAT $16,468,647.00
  • Revenue This Year
  • NKTR $12.85
  • RCAT $125.47
  • Revenue Next Year
  • NKTR N/A
  • RCAT $167.75
  • P/E Ratio
  • NKTR N/A
  • RCAT N/A
  • Revenue Growth
  • NKTR 5.53
  • RCAT 95.46
  • 52 Week Low
  • NKTR $0.47
  • RCAT $0.56
  • 52 Week High
  • NKTR $1.93
  • RCAT $12.57
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 33.04
  • RCAT 59.10
  • Support Level
  • NKTR $0.89
  • RCAT $7.76
  • Resistance Level
  • NKTR $1.04
  • RCAT $9.99
  • Average True Range (ATR)
  • NKTR 0.07
  • RCAT 1.35
  • MACD
  • NKTR -0.00
  • RCAT -0.09
  • Stochastic Oscillator
  • NKTR 14.81
  • RCAT 62.99

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.

Share on Social Networks: